InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: EndoTarget post# 342084

Tuesday, 05/24/2022 12:34:53 PM

Tuesday, May 24, 2022 12:34:53 PM

Post# of 346141
EndoTarget, and NO company will take over MORE then the issued outstanding shares.

So if we have (say) 60Milj issued outstanding shares and there are 72 to 80Milj share in rotation due to short selling and 'lending on lending', then when Nick bring an acquisition offer he CANNOT bring it for more then 60Milj shares when he devides the price by the number of shares.

So one can see the problem! An off, say 60Mil, would mean 1$ per share. However, to get that dollar EVERY lender must cancel the related lending contract. That means every shorter must close its position an BUY the shares. But below 1$ that will be impossible. So they will need to up the price for REAL shareholders to sell. hence the price will go UP above 1$. Then Nick cannot sell at 1$ a share when the price at market would be 1.5$. etc, etc, etc.

AIMO

All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News